DZ3367A1 - 2-AMINOTHIAZOLINE DERIVATIVES AND THEIR USE AS NO-SYNTHASE INHIBITORS - Google Patents
2-AMINOTHIAZOLINE DERIVATIVES AND THEIR USE AS NO-SYNTHASE INHIBITORSInfo
- Publication number
- DZ3367A1 DZ3367A1 DZ013367A DZ013367A DZ3367A1 DZ 3367 A1 DZ3367 A1 DZ 3367A1 DZ 013367 A DZ013367 A DZ 013367A DZ 013367 A DZ013367 A DZ 013367A DZ 3367 A1 DZ3367 A1 DZ 3367A1
- Authority
- DZ
- Algeria
- Prior art keywords
- synthase inhibitors
- aminothiazoline
- derivatives
- aminothiazoline derivatives
- synthase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0007397A FR2810037B1 (en) | 2000-06-09 | 2000-06-09 | USE OF 2-AMINOTHIAZOLINE DERIVATIVES AS INDUCTIBLE NO-SYNTHASE INHIBITORS |
PCT/FR2001/001760 WO2001094325A1 (en) | 2000-06-09 | 2001-06-07 | 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
DZ3367A1 true DZ3367A1 (en) | 2001-12-13 |
Family
ID=8851134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DZ013367A DZ3367A1 (en) | 2000-06-09 | 2001-06-07 | 2-AMINOTHIAZOLINE DERIVATIVES AND THEIR USE AS NO-SYNTHASE INHIBITORS |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP1299365B1 (en) |
JP (1) | JP4238026B2 (en) |
KR (1) | KR20030025931A (en) |
CN (1) | CN1202096C (en) |
AP (1) | AP2002002708A0 (en) |
AR (1) | AR029937A1 (en) |
AT (1) | ATE305460T1 (en) |
AU (1) | AU2001266124A1 (en) |
BR (1) | BR0111986A (en) |
CA (1) | CA2411760C (en) |
DE (1) | DE60113689T2 (en) |
DK (1) | DK1299365T3 (en) |
DZ (1) | DZ3367A1 (en) |
EA (1) | EA200300010A1 (en) |
EC (1) | ECSP024375A (en) |
ES (1) | ES2248347T3 (en) |
FR (1) | FR2810037B1 (en) |
HK (1) | HK1057900A1 (en) |
HR (1) | HRP20020970A2 (en) |
HU (1) | HUP0301000A2 (en) |
IL (1) | IL153328A0 (en) |
MA (1) | MA25814A1 (en) |
MX (1) | MXPA02012071A (en) |
NO (1) | NO20025884L (en) |
NZ (1) | NZ522968A (en) |
OA (1) | OA12286A (en) |
PL (1) | PL360285A1 (en) |
WO (1) | WO2001094325A1 (en) |
ZA (1) | ZA200209769B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60140964D1 (en) * | 2001-09-26 | 2010-02-11 | Yissum Res Dev Co | Sphingolipiden |
CA2465691C (en) * | 2001-11-09 | 2011-07-19 | Aventis Pharma S.A. | 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase |
DE60234117D1 (en) * | 2001-11-09 | 2009-12-03 | Aventis Pharma Sa | 2-AMINO-4-PYRIDYLMETHYL-THIAZOLINE DERIVATIVES AND THEIR USE AS INDUCIBLE NO-SYNTHASE INHIBITORS |
PL370324A1 (en) * | 2001-11-09 | 2005-05-16 | Aventis Pharma S.A. | 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
AU2002238889A1 (en) * | 2002-03-14 | 2003-09-22 | Dainippon Pharmaceutical Co., Ltd. | Nitrogen monoxide synthase inhibitors |
CA2494323C (en) * | 2002-08-07 | 2011-01-25 | Neuraxon Inc. | Amino benzothiazole compounds with nos inhibitory activity |
DE10332560B4 (en) * | 2003-07-11 | 2010-07-08 | Chiracon Gmbh | Process for the preparation of β-heteroaryl-2-alanine compounds via 2-amino-2- (heteroarylmethyl) -carboxylic acid compounds |
KR101800507B1 (en) | 2015-09-18 | 2018-01-18 | 주식회사 이엔이티아이 | How to take advantage of the purification plants equipment and self-cleaning screen to clean up pollution by continue flowing sewage and process wastewater into the river |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5066662A (en) * | 1990-05-21 | 1991-11-19 | Warner-Lambert Company | Substituted oxazolidin-2-ones and 1,2,4-oxadiazolin-5-ones and derivatives thereof acting at muscarinic receptors |
SI9300616A (en) * | 1992-11-27 | 1994-06-30 | Wellcome Found | Enzyme inhibitors |
CA2173468A1 (en) * | 1993-10-21 | 1995-04-27 | Donald W. Hansen, Jr. | Amidino derivatives useful as nitric oxide synthase inhibitors |
AU4149696A (en) * | 1994-11-15 | 1996-06-06 | Merck & Co., Inc. | Substituted heterocycles as inhibitors of nitric oxide synthase |
AU2223501A (en) * | 1999-12-24 | 2001-07-09 | Kyowa Hakko Kogyo Co. Ltd. | Fused purine derivatives |
-
2000
- 2000-06-09 FR FR0007397A patent/FR2810037B1/en not_active Expired - Fee Related
-
2001
- 2001-06-07 AR ARP010102730A patent/AR029937A1/en not_active Application Discontinuation
- 2001-06-07 MX MXPA02012071A patent/MXPA02012071A/en active IP Right Grant
- 2001-06-07 EP EP01943580A patent/EP1299365B1/en not_active Expired - Lifetime
- 2001-06-07 DE DE60113689T patent/DE60113689T2/en not_active Expired - Lifetime
- 2001-06-07 NZ NZ522968A patent/NZ522968A/en unknown
- 2001-06-07 DZ DZ013367A patent/DZ3367A1/en active
- 2001-06-07 BR BR0111986-9A patent/BR0111986A/en not_active Application Discontinuation
- 2001-06-07 HU HU0301000A patent/HUP0301000A2/en unknown
- 2001-06-07 PL PL36028501A patent/PL360285A1/en unknown
- 2001-06-07 CN CNB01813386XA patent/CN1202096C/en not_active Expired - Fee Related
- 2001-06-07 DK DK01943580T patent/DK1299365T3/en active
- 2001-06-07 IL IL15332801A patent/IL153328A0/en unknown
- 2001-06-07 AP APAP/P/2002/002708A patent/AP2002002708A0/en unknown
- 2001-06-07 CA CA002411760A patent/CA2411760C/en not_active Expired - Fee Related
- 2001-06-07 OA OA1200200372A patent/OA12286A/en unknown
- 2001-06-07 AU AU2001266124A patent/AU2001266124A1/en not_active Abandoned
- 2001-06-07 ES ES01943580T patent/ES2248347T3/en not_active Expired - Lifetime
- 2001-06-07 EA EA200300010A patent/EA200300010A1/en unknown
- 2001-06-07 JP JP2002501875A patent/JP4238026B2/en not_active Expired - Fee Related
- 2001-06-07 KR KR1020027016766A patent/KR20030025931A/en not_active Application Discontinuation
- 2001-06-07 AT AT01943580T patent/ATE305460T1/en not_active IP Right Cessation
- 2001-06-07 WO PCT/FR2001/001760 patent/WO2001094325A1/en active IP Right Grant
-
2002
- 2002-12-02 ZA ZA200209769A patent/ZA200209769B/en unknown
- 2002-12-06 NO NO20025884A patent/NO20025884L/en not_active Application Discontinuation
- 2002-12-06 HR HR20020970A patent/HRP20020970A2/en not_active Application Discontinuation
- 2002-12-09 EC EC2002004375A patent/ECSP024375A/en unknown
- 2002-12-09 MA MA26939A patent/MA25814A1/en unknown
-
2004
- 2004-02-06 HK HK04100771A patent/HK1057900A1/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA27001A1 (en) | NOVEL SPIROTRICYCLIC DERIVATIVES AND THEIR USE AS PHOSPHO-DIESTERASE-7 INHIBITORS | |
AR028576A1 (en) | USEFUL B-CARBOLINE DERIVATIVES AS PHOSPHODESTERASE INHIBITORS | |
AR028575A1 (en) | USED PIRROLOPIRIDINONE DERIVATIVES AS PHOSPHODESTERASE INHIBITORS | |
PT1181017E (en) | METALOPROTEASE INHIBITORS | |
AR028253A1 (en) | INHIBITORS OF THE GLUCOGENO FOSFORILASA | |
AR028567A1 (en) | NEW DERIVATIVES OF FENIL-PROPARGILETER | |
EE200200715A (en) | Substituted quinazoline derivatives and their use as inhibitors | |
PT1224195E (en) | TGLS2 INHIBITOR C-ARYL-GLYCOSIDES | |
AR028596A1 (en) | NEW DERIVATIVES OF PHENYLGLYCIN | |
PT1268480E (en) | 8-QUINOLINYL-XANTIN AND 8-ISOKINOLINYL-XANTIN DERIVATIVES AS PDE 5 INHIBITORS | |
DK1244647T3 (en) | Quinzoline derivatives as VIGF inhibitors | |
ATE245142T1 (en) | NO-SYNTHASE INHIBITORS | |
PT946512E (en) | 6-PHENYLPYRIDYL-2-AMINE DERIVATIVES AS US INHIBITORS | |
PT1194404E (en) | ASPARTIL-PROTEASE INHIBITORS | |
NO20024997D0 (en) | 2-guanidino-4-arylquinazolines as NHE-3 inhibitors | |
PT1097127E (en) | DIACYL-HYDRAZINE DERIVATIVES AS INTEGRIN INHIBITORS | |
DK1272488T3 (en) | Tri-aryl-substituted ethane-PDE4 inhibitors | |
NO20016201D0 (en) | Tienopyrimidines as phosphodiesterase inhibitors | |
NO20020873L (en) | Removable absorbent article | |
EE200100371A (en) | Amidinobenzylamine derivatives and their use as thrombin inhibitors | |
AR028068A1 (en) | NEW DERIVATIVES OF 1,1-DIOXOTIOCROMANO AND ITS USE AS THROMBIN INHIBITORS | |
DZ3367A1 (en) | 2-AMINOTHIAZOLINE DERIVATIVES AND THEIR USE AS NO-SYNTHASE INHIBITORS | |
PT1351959E (en) | NEW PLEUROMUTILINE DERIVATIVES | |
PT1339695E (en) | FARNESILTRANSFERASE INHIBITORS | |
ATE262517T1 (en) | THIOPYRANE DERIVATIVES AS MMP INHIBITORS |